<DOC>
	<DOCNO>NCT00010803</DOCNO>
	<brief_summary>This study determine effect 240mg/day Ginkgo biloba decrease incidence dementia specifically Alzheimer 's disease ( AD ) , slow cognitive decline functional disability , reduce incidence cardiovascular disease , decrease total mortality .</brief_summary>
	<brief_title>Ginkgo Biloba Prevention Trial Older Individuals</brief_title>
	<detailed_description>Participants study randomized trial 240 mg Ginkgo biloba compare placebo healthy men woman , least 75 year old . The trial last approximately 8 year . The intervention consider unsuccessful participant succumb dementia , include Alzheimer 's Disease vascular dementia . There four clinical center : Pittsburgh , PA ; Hagerstown , MD ; Winston-Salem , NC ; Sacramento , CA ; Coordinating Center University Washington , Seattle . There clinic visit every 6 month determine morbidity , mortality change cognition include repeat ADAS , CDR , 10 battery neuropsychological evaluation informant interview . The primary endpoint dementia , specifically Alzheimer 's disease , secondary endpoint include incidence vascular disease , change cognitive function score time , total mortality change functional status . The diagnosis dementia base neuropsychological testing , neurological exam , MRI , functional measurement , review central adjudication committee classify DSM IV , NINCDS criterion ADRTC criterion vascular disease .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<criteria>Nondemented participant Willing participate sevenyear followup trial Ginkgo Biloba English usual language Willing informant frequent contact participant Currently anticoagulant therapy Cancer diagnose treat within past two year ( except skin cancer ) Participant class III IV congestive heart failure Currently treat psychopharmacological drug depression Hospitalized depression within last year Taking Aricept ( similar agent ) cognitive problem dementia Baseline blood creatinine &gt; 2 Baseline SGGT marker liver function ( 3 x normal &gt; or=90 IU ) Baseline hematocrit &lt; 30 Baseline white blood count &gt; or=15,000</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>